NanoViricides Partners with CRO to Advance Phase II Clinical Trials for NV-387Business PenJanuary 27, 2025 January 27, 2025 NanoViricides, Inc. (NYSE American: NNVC), based in Shelton, Connecticut, has announced a significant step in its clinical development pipeline by engaging a Clinical Research Organization...
